A similar trend was observed in the non-conventional lipid-related ASCVD biomarkers (PON-1 and LCAT), where myocardial infarction and IHD patients were noted to have the lowest concentrations of plasma PON-1 and LCAT. This evidence concerns the gene PON1 and myocardial ischemia.